Randomized phase III trial of paclitaxel/carboplatin with or without PF-3512676 (toll-like receptor 9 agonist) as first-line treatment for advanced non-small-cell lung cancer

Vera Hirsh, Luis Paz-Ares, Michael Boyer, Rafael Rosell, Gary Middleton, Wilfried E E Eberhardt, Aleksandra Szczesna, Pavel Reiterer, Mansoor Saleh, Oscar Arrieta, Emilio Bajetta, Roy T. Webb, Johannes Raats, Rebecca J. Benner, Camilla Fowst, Sandra J. Meech, David Readett, Joan H. Schiller

Research output: Contribution to journalArticle

92 Scopus citations

Fingerprint Dive into the research topics of 'Randomized phase III trial of paclitaxel/carboplatin with or without PF-3512676 (toll-like receptor 9 agonist) as first-line treatment for advanced non-small-cell lung cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences